Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Transcontinental Realty Investors
TCI
$318M
| $830K | ﹤0.01% |
20,825
+10,155
| +95% | +$342K |
|
|
SBBP
3452
DELISTED
Strongbridge Biopharma plc.
SBBP
| $827K | ﹤0.01% |
395,460
+60,076
| +18% | +$115K |
|
3453
Lee Enterprises
LEE
$181M
| $822K | ﹤0.01% |
57,886
+103
| +0.2% | +$1.84K |
|
3454
Victory Capital Holdings
VCTR
$6.99B
| $820K | ﹤0.01% |
39,116
+8,258
| +27% | +$150K |
|
3455
Maui Land & Pineapple Co
MLP
$319M
| $814K | ﹤0.01% |
72,369
-5,596
| -7% | -$59.6K |
|
3456
Gran Tierra Energy
GTE
$337M
| $803K | ﹤0.01% |
62,184
-839
| -1% | -$9.15K |
|
|
LNAI
3457
Lunai Bioworks
LNAI
$10.9M
| $797K | ﹤0.01% |
1,984
+1,366
| +221% | +$601K |
|
|
SBOW
3458
DELISTED
SilverBow Resources, Inc.
SBOW
| $797K | ﹤0.01% |
80,526
-7,414
| -8% | -$70.2K |
|
|
NS
3459
DELISTED
NuStar Energy L.P.
NS
| $794K | ﹤0.01% |
30,698
| – | – |
|
3460
Valhi
VHI
$463M
| $789K | ﹤0.01% |
35,176
-2,197
| -6% | -$50.4K |
|
3461
Tempest Therapeutics
TPST
$18.9M
| $786K | ﹤0.01% |
598
+23
| +4% | +$32.4K |
|
|
KDNY
3462
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $786K | ﹤0.01% |
133,162
-12,980
| -9% | -$70.5K |
|
|
ETNB
3463
DELISTED
89bio
ETNB
| $784K | ﹤0.01% |
+29,814
| New | +$830K |
|
|
LX
3464
LexinFintech Holdings
LX
$242M
| $781K | ﹤0.01% |
56,243
-7,118
| -11% | -$81.6K |
|
3465
Cyclerion Therapeutics
CYCN
$16.7M
| $780K | ﹤0.01% |
14,348
+183
| +1% | +$17.1K |
|
3466
Rimini Street
RMNI
$449M
| $774K | ﹤0.01% |
199,568
+1,578
| +0.8% | +$6.32K |
|
3467
Vanguard S&P 500 Growth ETF
VOOG
$27.1B
| $772K | ﹤0.01% |
26,556
+2,448
| +10% | +$68K |
|
|
BXG
3468
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
| $771K | ﹤0.01% |
74,570
-4,832
| -6% | -$47.5K |
|
3469
Safe Bulkers
SB
$746M
| $769K | ﹤0.01% |
452,200
-1,237
| -0.3% | -$2.15K |
|
3470
NextDecade
NEXT
$1.8B
| $766K | ﹤0.01% |
124,637
-1,692
| -1% | -$10.5K |
|
|
OXFD
3471
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $754K | ﹤0.01% |
45,407
-54,876
| -55% | -$890K |
|
3472
Columbia Emerging Markets Consumer ETF
ECON
$304M
| $751K | ﹤0.01% |
32,000
| – | – |
|
3473
Purple Innovation
PRPL
$31.6M
| $749K | ﹤0.01% |
3,437
+1,825
| +113% | +$352K |
|
3474
American Realty Investors
ARL
$246M
| $748K | ﹤0.01% |
43,631
+13,092
| +43% | +$195K |
|
3475
iShares MSCI Switzerland ETF
EWL
$2.23B
| $748K | ﹤0.01% |
18,405
+6,982
| +61% | +$270K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.